Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1

Conditions

Polycystic Ovary Syndrome 9Motor Activity 7Prostatic Neoplasms 3Colorectal Neoplasms 2Urinary Bladder Neoplasms 1Rectal Neoplasms 1Non-Muscle Invasive Bladder Neoplasms 1Neoplasms 1Multiple Endocrine Neoplasia Type 1 1Lymphoma, Follicular 1Lupus Erythematosus, Systemic 1Insulin Resistance 1Hematologic Neoplasms 1Head and Neck Neoplasms 1Fatigue 1Diabetes Mellitus, Type 1 1Cardiovascular Diseases 1Cardiotoxicity 1Carcinoma, Hepatocellular 1Breast Neoplasms 1Arthritis, Rheumatoid 1Anxiety Disorders 1

Interventions

Cyclophosphamide 32Tacrolimus 29fludarabine 27Mycophenolic Acid 23fludarabine phosphate 22Busulfan 19Whole-Body Irradiation 18Melphalan 16Methotrexate 15Antilymphocyte Serum 14Rituximab 12Bortezomib 11Stem Cell Transplantation 10Cyclosporine 10thymoglobulin 9Sirolimus 9Granulocyte Colony-Stimulating Factor 9Peripheral Blood Stem Cell Transplantation 8Thiotepa 7Interviews as Topic 7Filgrastim 7Dexamethasone 7Clofarabine 7Blood Specimen Collection 6Alemtuzumab 6merphos 5Voriconazole 5Standard of Care 5Nivolumab 5Lenalidomide 5

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Completed × Hematologic Neoplasms × High-Intensity Interval Training × Clear all
NCT03823651 2024-09-27

A Research Program Targeting Pre- and Peri-transplant Optimization Program (R-PPOP)

Duke University

Phase NA Completed
29 enrolled 14 charts
Other hematologic neoplasm

Hematologic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡